OmniAb
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OmniAb and other ETFs, options, and stocks.About OABI
OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies.
CEOMatthew William Foehr
CEOMatthew William Foehr
Employees114
Employees114
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded2015
Founded2015
Employees114
Employees114
OABI Key Statistics
Market cap289.35M
Market cap289.35M
Price-Earnings ratio-3.39
Price-Earnings ratio-3.39
Dividend yield—
Dividend yield—
Average volume435.37K
Average volume435.37K
High today$2.04
High today$2.04
Low today$1.97
Low today$1.97
Open price$1.99
Open price$1.99
Volume470.77K
Volume470.77K
52 Week high$4.13
52 Week high$4.13
52 Week low$1.22
52 Week low$1.22
Stock Snapshot
The current OmniAb(OABI) stock price is $2.00, with a market capitalization of 289.35M. The stock trades at a price-to-earnings (P/E) ratio of -3.39.
As of 2025-12-11, OmniAb(OABI) stock has fluctuated between $1.97 and $2.04. The current price stands at $2.00, placing the stock +1.5% above today's low and -1.7% off the high.
OmniAb(OABI) shares are trading with a volume of 470.77K, against a daily average of 435.37K.
In the last year, OmniAb(OABI) shares hit a 52-week high of $4.13 and a 52-week low of $1.22.
In the last year, OmniAb(OABI) shares hit a 52-week high of $4.13 and a 52-week low of $1.22.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own OABI. This list is generated using Robinhood data, and it’s not a recommendation.